23andMe Re-Opens Data Auction With $305 Million Bid From Former CEO
The Washington Post reported: The fate of genetic data belonging to millions of 23andMe customers is again up in the air, as the bankrupt company seeks a judge’s permission to consider another bid from its co-founder and undisclosed financial backers after previously accepting an offer from Regeneron Pharmaceuticals. A nonprofit research institute backed by Anne Wojcicki, 23andMe's co-founder and former